Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Cellartis AB
Mandate

Vinge advises Cellartis AB

September 26, 2011

Vinge has advised the owners of Cellartis in connection with the sale of Cellartis AB to Cellectis S.A., a company listed on NYSE Euronext in Paris. The owners consist of InnovationsKapital among other venture capital investers as well as the company’s founders and employees. Cellartis has developed world-leading products based on pluripotent stem cells. Cellartis and Cellectis will jointly become a world-leading actor within R&D and development of products and services relating to regenerative and medical applications.

The purchase price consists of a cash element of € 16,400,000, and 1,930,000 in newly-issued Cellectis shares.

Vinge’s team primarily consisted of Anders Strid, Fredrik Sonander, Michael Sterner, Johanna Björnum Nyström, Emma Kero Ljungberg and Tove Bremell.

 
   

Related

Vinge advises Consolid Equity in connection with the establishment of Petra Group

 Vinge has advised Consolid Equity Investment AB ("Consolid Equity") on the acquisition of Ström & Gulliksson, one of the leading patent agencies in the Nordics. The acquisition forms part of the establishment of Petra Group, a European platform aimed at consolidating patent agencies across Europe to combine expertise and resources primarily within patents and trademarks. Consolid acts as a strategic partner in the new group.
July 08, 2026

Vinge has advised Scandic on new credit facilities with SEK 7.5 billion credit facilities

 Vinge has represented Scandic Hotels Group AB (publ) in connection with a facilities agreement for SEK 7,500,000,000 with a syndicate of banks, arranged by DNB Carnegie Investment Bank AB and Nordea Bank Abp, filial i Sverige.
July 08, 2026

Vinge has advised Vitamin Well and its majority shareholders Cinven, Bridgepoint and the founders on Vitamin Well's combination with EMPWR

 Vinge has advised Vitamin Well and its majority shareholders Cinven, the founders of Vitamin Well and Bridgepoint on Vitamin Well's acquisition of EMPWR Nutrition Group from majority seller Waterland Private Equity Investments.
July 03, 2026